Ocular adnexal lymphomas are a group of heterogeneous neoplasms representing
approximately 1–2% of non-Hodgkin lymphomas and 8% of extranodal lymphomas. The …

Primary lymphomas of bone are uncommon malignancies. The vast majority of them are non-
Hodgkin lymphoma (NHL), whereas primary Hodgkin lymphoma (HL) of bone is extremely …

The diagnosis of classic Hodgkin lymphoma requires immunohistochemical confirmation in
most cases and one can argue for these studies as standard-of-care in the diagnostic …

Background The variability of prognosis within a pathological stage of gastric cancer (GC) at
presentation, underscores the need for specific biological markers to identify subgroups of …

Abstract Cyclin D2 (CCND2) is abnormally overexpressed in many tumor types and has
been associated with tumor cell proliferation. Although the important role of miR-1297 is well …

Cyclins are key regulators of cell cycle progression and survival. Particularly cyclins D
(cyclin D1, D2, and D3) act in response to the mitogenic stimulation and are pivotal …

Despite improvement in the treatment of advanced classical Hodgkin lymphoma,
approximately 30% of patients relapse or die as result of the disease. Current predictive …

Myc oncogenic transcription factor is known to inhibit tumor suppressive microRNAs
(miRNAs), resulting in greater expression of their target protein related to cell cycle, invasion …

Background: Increased proliferation rate may be associated with inferior outcome in patients
with Hodgkin lymphoma (HL). Minichromosome maintenance proteins (MCMs) and D–type …

OBJECTIVE: The prognosis of patients with Hodgkin's lymphoma (HL) has been significantly
improved as a result of combination treatment including chemotherapy. However, some …